Int Urogynecol J (2017) 28:1351–1356 DOI 10.1007/s00192-017-3271-1 ORIGINAL ARTICLE Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice 1,2 3 4 Linda Collins & Sanchutha Sathiananthamoorthy & Mandy Fader & James Malone-Lee Received: 7 November 2016 /Accepted: 5 January 2017 /Published online: 23 January 2017 The International Urogynecological Association 2017 Abstract CISC prior to injections and continued. None of the 196 pa- Introduction and hypothesis Botulinum toxin has become a tients developed acute retention or significant voiding widely adopted treatment for patients with recalcitrant over- symptoms. active bladder (OAB) symptoms. Some recommend clean in- Conclusions Our study indicates that routine administration termittent self-catheterisation (CISC) if a postvoid residual of CISC based on an arbitrary PVR volume is unlikely to (PVR) >200 ml posttreatment, but there is no evidence for this confer benefit. In order to avoid patients being deterred from recommendation. The aim of this study was to identify wheth- botulinum treatment, we recommend that CISC be reserved er abstinence from CISC as a routine strategy for patients with for those who have troublesome voiding symptoms as well as a PVR following intradetrusor botulinum toxin injections is a raised PVR. It is unlikely that CISC, initiated
International Urogynecology Journal – Springer Journals
Published: Jan 23, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera